Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for VYGR
| Stock Name | Voyager Therapeutics Inc |
| Ticker | VYGR(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US92915B1061 |
| LEI | 54930082S4XVR0ZWCC74 |
Show aggregate VYGR holdings
News associated with VYGR
- HC Wainwright Reiterates “Buy” Rating for Voyager Therapeutics (NASDAQ:VYGR)
- Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $30.00 target price on the stock. Separately, Wedbush lowered their price objective on Voyager Therapeutics from $9.00 to $8.00 and set an “outperform” rating […] - 2025-09-17 02:30:53
- Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Recommendation of “Buy” from Brokerages
- Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have been given an average rating of “Buy” by the eight brokerages that are covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month […] - 2025-07-30 02:46:52
- Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.39
- Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have received an average recommendation of “Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […] - 2025-07-08 02:38:54
- Voyager Therapeutics (NASDAQ:VYGR) and Prime Medicine (NYSE:PRME) Head-To-Head Contrast
- Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) and Prime Medicine (NYSE:PRME – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation. Institutional and Insider Ownership 48.0% of Voyager […] - 2025-06-18 02:26:52
- Analysts Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.39
- Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have received an average recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year […] - 2025-06-13 02:32:50
- BNP Paribas Financial Markets Trims Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- BNP Paribas Financial Markets decreased its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 87.8% in the fourth quarter, Holdings Channel reports. The firm owned 6,025 shares of the company’s stock after selling 43,210 shares during the period. BNP Paribas Financial Markets’ holdings in Voyager Therapeutics were worth $34,000 at the end of […] - 2025-06-05 04:18:54
- Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Deutsche Bank AG
- Deutsche Bank AG trimmed its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 45.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 42,470 shares of the company’s stock after selling 35,898 shares during the period. Deutsche Bank AG’s holdings in Voyager Therapeutics were worth $241,000 at the end of the […] - 2025-06-02 04:42:59
- State of Wyoming Trims Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- State of Wyoming decreased its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 36.8% during the fourth quarter, Holdings Channel reports. The fund owned 8,904 shares of the company’s stock after selling 5,191 shares during the period. State of Wyoming’s holdings in Voyager Therapeutics were worth $50,000 as of its most recent filing […] - 2025-05-30 05:08:56
- Man Group plc Purchases New Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- Man Group plc acquired a new position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 41,200 shares of the company’s stock, valued at approximately $234,000. Man Group plc owned 0.08% of Voyager Therapeutics […] - 2025-05-28 05:00:56
- Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $13.39 Consensus PT from Brokerages
- Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have earned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-05-19 02:32:50
- Legal & General Group Plc Acquires 7,597 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- Legal & General Group Plc lifted its stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 65.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 19,245 shares of the company’s stock after buying an additional 7,597 shares during the period. Legal & General Group Plc’s holdings in Voyager Therapeutics were worth […] - 2025-05-02 04:30:49
- XTX Topco Ltd Invests $178,000 in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- XTX Topco Ltd bought a new position in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund bought 31,375 shares of the company’s stock, valued at approximately $178,000. Other hedge funds have also recently modified their holdings of the company. Picton Mahoney Asset Management grew its […] - 2025-04-29 05:00:58
- Wellington Management Group LLP Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- Wellington Management Group LLP raised its stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 13.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 261,251 shares of the company’s stock after acquiring an additional 31,882 shares during the […] - 2025-04-14 04:50:52
- HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR)
- Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $30.00 price target on the stock. VYGR has been the subject of a number of other reports. StockNews.com cut shares of Voyager Therapeutics from a […] - 2025-04-10 02:58:47
- Bank of New York Mellon Corp Cuts Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- Bank of New York Mellon Corp lessened its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 22.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 193,315 shares of the company’s stock after selling 56,213 shares during the period. Bank of New York Mellon Corp’s holdings […] - 2025-03-25 05:14:53
- Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $15.72 Average Price Target from Analysts
- Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price […] - 2025-03-05 04:20:51
- Allspring Global Investments Holdings LLC Buys 7,573 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)
- Allspring Global Investments Holdings LLC boosted its position in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 23.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 39,313 shares of the company’s stock after acquiring an additional 7,573 shares during […] - 2025-02-26 06:42:54
- Voyager Therapeutics (NASDAQ:VYGR) Receives “Outperform” Rating from Wedbush
- Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report published on Tuesday morning,RTT News reports. Wedbush currently has a $9.00 price target on the stock, down from their prior price target of $11.00. Several other brokerages have also recently issued reports on VYGR. Cantor Fitzgerald started coverage […] - 2025-02-12 07:14:56
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) VYGR holdings
| Date | Number of VYGR Shares Held | Base Market Value of VYGR Shares | Local Market Value of VYGR Shares | Change in VYGR Shares Held | Change in VYGR Base Value | Current Price per VYGR Share Held | Previous Price per VYGR Share Held |
|---|
| 2025-12-03 (Wednesday) | 35,906 | USD 151,882 | USD 151,882 | 0 | USD 16,516 | USD 4.22999 | USD 3.77001 |
| 2025-12-02 (Tuesday) | 35,906 | USD 135,366 | USD 135,366 | 1,335 | USD -1,189 | USD 3.77001 | USD 3.94999 |
| 2025-12-01 (Monday) | 34,571 | USD 136,555 | USD 136,555 | 0 | USD -4,840 | USD 3.94999 | USD 4.08999 |
| 2025-11-28 (Friday) | 34,571 | USD 141,395 | USD 141,395 | 89 | USD 2,433 | USD 4.08999 | USD 4.02999 |
| 2025-11-27 (Thursday) | 34,482 | USD 138,962 | USD 138,962 | 0 | USD 0 | USD 4.02999 | USD 4.02999 |
| 2025-11-26 (Wednesday) | 34,482 | USD 138,962 | USD 138,962 | 267 | USD 3,128 | USD 4.02999 | USD 3.97001 |
| 2025-11-25 (Tuesday) | 34,215 | USD 135,834 | USD 135,834 | 445 | USD -2,623 | USD 3.97001 | USD 4.1 |
| 2025-11-24 (Monday) | 33,770 | USD 138,457 | USD 138,457 | 89 | USD -2,330 | USD 4.1 | USD 4.18001 |
| 2025-11-21 (Friday) | 33,681 | USD 140,787 | USD 140,787 | 0 | USD 3,032 | USD 4.18001 | USD 4.08999 |
| 2025-11-20 (Thursday) | 33,681 | USD 137,755 | USD 137,755 | -356 | USD -3,839 | USD 4.08999 | USD 4.16 |
| 2025-11-19 (Wednesday) | 34,037 | USD 141,594 | USD 141,594 | 89 | USD -3,703 | USD 4.16 | USD 4.27999 |
| 2025-11-18 (Tuesday) | 33,948 | USD 145,297 | USD 145,297 | 534 | USD 7,965 | USD 4.27999 | USD 4.11001 |
| 2025-11-17 (Monday) | 33,414 | USD 137,332 | USD 137,332 | 178 | USD 6,715 | USD 4.11001 | USD 3.92999 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of VYGR by Blackrock for IE00BDZVHG35
Show aggregate share trades of VYGR| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-12-02 | BUY | 1,335 | | | 3.770* | | 4.33 |
| 2025-11-28 | BUY | 89 | | | 4.090* | | 4.33 |
| 2025-11-26 | BUY | 267 | | | 4.030* | | 4.33 |
| 2025-11-25 | BUY | 445 | | | 3.970* | | 4.33 |
| 2025-11-24 | BUY | 89 | | | 4.100* | | 4.33 |
| 2025-11-20 | SELL | -356 | | | 4.090* | | 4.34 Profit of 1,544 on sale |
| 2025-11-19 | BUY | 89 | | | 4.160* | | 4.34 |
| 2025-11-18 | BUY | 534 | | | 4.280* | | 4.34 |
| 2025-11-17 | BUY | 178 | | | 4.110* | | 4.34 |
| 2025-11-14 | BUY | 89 | | | 3.930* | | 4.34 |
| 2025-11-12 | BUY | 89 | | | 4.250* | | 4.34 |
| 2025-11-10 | BUY | 88 | | | 4.260* | | 4.34 |
| 2025-11-06 | BUY | 88 | | | 4.220* | | 4.35 |
| 2025-11-04 | BUY | 89 | | | 4.160* | | 4.35 |
| 2025-10-30 | BUY | 445 | 4.660 | 4.480 | 4.498 | USD 2,002 | 4.34 |
| 2025-10-29 | BUY | 178 | 4.610 | 4.725 | 4.713 | USD 839 | 4.34 |
| 2025-10-22 | SELL | -348 | 4.770 | 4.990 | 4.968 | USD -1,729 | 4.33 Loss of -221 on sale |
| 2025-10-20 | BUY | 174 | 5.070 | 5.120 | 5.115 | USD 890 | 4.32 |
| 2025-10-17 | BUY | 433 | 4.950 | 5.270 | 5.238 | USD 2,268 | 4.32 |
| 2025-10-15 | BUY | 688 | 5.290 | 5.380 | 5.371 | USD 3,695 | 4.31 |
| 2025-10-03 | BUY | 616 | 4.860 | 4.860 | 4.860 | USD 2,994 | 4.31 |
| 2025-10-02 | BUY | 88 | 4.720 | 4.940 | 4.918 | USD 433 | 4.30 |
| 2025-09-30 | BUY | 176 | 4.670 | 4.730 | 4.724 | USD 831 | 4.30 |
| 2025-09-26 | BUY | 176 | 4.520 | 4.530 | 4.529 | USD 797 | 4.30 |
| 2025-09-25 | BUY | 176 | 4.090 | 4.200 | 4.189 | USD 737 | 4.30 |
| 2025-09-18 | BUY | 88 | 4.490 | 4.560 | 4.553 | USD 401 | 4.30 |
| 2025-09-17 | BUY | 264 | 4.260 | 4.530 | 4.503 | USD 1,189 | 4.30 |
| 2025-07-17 | SELL | -176 | 3.220 | 3.350 | 3.337 | USD -587 | 4.32 Profit of 173 on sale |
| 2025-07-11 | SELL | -704 | 3.490 | 3.620 | 3.607 | USD -2,539 | 4.34 Profit of 519 on sale |
| 2025-07-02 | BUY | 4,840 | 3.200 | 3.430 | 3.407 | USD 16,490 | 4.37 |
| 2025-06-25 | BUY | 176 | 2.940 | 3.030 | 3.021 | USD 532 | 4.41 |
| 2025-06-11 | BUY | 176 | 3.380 | 3.630 | 3.605 | USD 634 | 4.50 |
| 2025-06-10 | BUY | 176 | 3.460 | 3.500 | 3.496 | USD 615 | 4.51 |
| 2025-06-04 | SELL | -88 | 3.320 | 3.510 | 3.491 | USD -307 | 4.55 Profit of 93 on sale |
| 2025-04-23 | BUY | 88 | 3.490 | 3.600 | 3.589 | USD 316 | 4.94 |
| 2025-04-10 | SELL | -704 | 2.990 | 3.080 | 3.071 | USD -2,162 | 5.12 Profit of 1,441 on sale |
| 2025-04-08 | SELL | -88 | 2.850 | 3.200 | 3.165 | USD -279 | 5.17 Profit of 176 on sale |
| 2025-04-07 | SELL | -88 | 3.060 | 3.200 | 3.186 | USD -280 | 5.19 Profit of 176 on sale |
| 2025-04-04 | SELL | -440 | 3.090 | 3.200 | 3.189 | USD -1,403 | 5.22 Profit of 892 on sale |
| 2025-04-01 | BUY | 352 | 3.370 | 3.460 | 3.451 | USD 1,215 | 5.26 |
| 2025-03-31 | SELL | -264 | 3.380 | 3.740 | 3.704 | USD -978 | 5.28 Profit of 417 on sale |
| 2025-03-14 | SELL | -1,408 | 3.900 | 4.160 | 4.134 | USD -5,821 | 5.51 Profit of 1,934 on sale |
| 2025-03-07 | SELL | -176 | 4.260 | 4.320 | 4.314 | USD -759 | 5.61 Profit of 229 on sale |
| 2025-03-04 | SELL | -88 | 3.960 | 4.000 | 3.996 | USD -352 | 5.69 Profit of 149 on sale |
| 2025-02-25 | BUY | 176 | 4.120 | 4.200 | 4.192 | USD 738 | 5.83 |
| 2025-02-19 | SELL | -88 | 4.300 | 4.420 | 4.408 | USD -388 | 5.95 Profit of 135 on sale |
| 2025-02-13 | BUY | 264 | 4.380 | 4.520 | 4.506 | USD 1,190 | 6.08 |
| 2025-02-12 | BUY | 88 | 4.420 | 4.440 | 4.438 | USD 391 | 6.11 |
| 2025-02-11 | BUY | 352 | 4.210 | 5.200 | 5.101 | USD 1,796 | 6.15 |
| 2024-12-30 | SELL | -4,658 | 5.590 | 5.730 | 5.716 | USD -26,625 | 6.42 Profit of 3,297 on sale |
| 2024-11-18 | SELL | -1,515 | 5.390 | 5.650 | 5.624 | USD -8,520 | 6.88 Profit of 1,896 on sale |
| 2024-11-08 | SELL | -101 | 7.130 | 7.200 | 7.193 | USD -726 | 6.86 Loss of -34 on sale |
| 2024-10-21 | SELL | -102 | 7.660 | 8.170 | 8.119 | USD -828 | 0.00 Loss of -828 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of VYGR
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 134,050 | 1,311 | 312,526 | 42.9% |
| 2025-09-18 | 117,027 | 2,694 | 296,379 | 39.5% |
| 2025-09-17 | 165,080 | 1,456 | 371,369 | 44.5% |
| 2025-09-16 | 194,832 | 0 | 353,912 | 55.1% |
| 2025-09-15 | 89,207 | 0 | 184,692 | 48.3% |
| 2025-09-12 | 203,692 | 0 | 480,753 | 42.4% |
| 2025-09-11 | 147,835 | 0 | 471,402 | 31.4% |
| 2025-09-10 | 135,304 | 0 | 359,695 | 37.6% |
| 2025-09-09 | 97,880 | 878 | 266,632 | 36.7% |
| 2025-09-08 | 174,291 | 855 | 410,093 | 42.5% |
| 2025-09-05 | 204,832 | 4,000 | 670,466 | 30.6% |
| 2025-09-04 | 95,176 | 0 | 318,862 | 29.8% |
| 2025-09-03 | 106,403 | 1,000 | 319,620 | 33.3% |
| 2025-09-02 | 87,175 | 0 | 390,146 | 22.3% |
| 2025-08-29 | 23,709 | 0 | 69,011 | 34.4% |
| 2025-08-28 | 30,479 | 0 | 134,576 | 22.6% |
| 2025-08-27 | 30,246 | 0 | 166,366 | 18.2% |
| 2025-08-26 | 72,282 | 0 | 244,507 | 29.6% |
| 2025-08-25 | 103,307 | 2,700 | 223,346 | 46.3% |
| 2025-08-22 | 70,907 | 0 | 313,480 | 22.6% |
| 2025-08-21 | 83,801 | 0 | 197,564 | 42.4% |
| 2025-08-20 | 93,851 | 0 | 282,664 | 33.2% |
| 2025-08-19 | 207,660 | 401 | 447,194 | 46.4% |
| 2025-08-18 | 66,924 | 0 | 173,663 | 38.5% |
| 2025-08-15 | 108,003 | 0 | 237,604 | 45.5% |
| 2025-08-14 | 70,741 | 0 | 184,045 | 38.4% |
| 2025-08-13 | 122,064 | 0 | 559,990 | 21.8% |
| 2025-08-12 | 161,668 | 1,382 | 445,136 | 36.3% |
| 2025-08-11 | 93,206 | 0 | 250,685 | 37.2% |
| 2025-08-08 | 195,215 | 8,750 | 602,544 | 32.4% |
| 2025-08-07 | 131,040 | 6,440 | 452,725 | 28.9% |
| 2025-08-06 | 183,376 | 0 | 280,585 | 65.4% |
| 2025-08-05 | 287,666 | 4,519 | 646,329 | 44.5% |
| 2025-08-04 | 413,423 | 30 | 778,414 | 53.1% |
| 2025-08-01 | 124,293 | 2 | 425,671 | 29.2% |
| 2025-07-31 | 142,381 | 0 | 492,537 | 28.9% |
| 2025-07-30 | 369,709 | 8,850 | 892,169 | 41.4% |
| 2025-07-29 | 120,744 | 2 | 290,853 | 41.5% |
| 2025-07-28 | 75,134 | 886 | 201,476 | 37.3% |
| 2025-07-25 | 56,604 | 142 | 194,143 | 29.2% |
| 2025-07-24 | 80,324 | 0 | 266,102 | 30.2% |
| 2025-07-23 | 80,319 | 0 | 284,336 | 28.2% |
| 2025-07-22 | 48,808 | 0 | 151,168 | 32.3% |
| 2025-07-21 | 86,625 | 1,853 | 238,519 | 36.3% |
| 2025-07-18 | 116,106 | 125 | 214,109 | 54.2% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy